Stay informed with the latest litigation news. Explore now

IP Verse

Teva Pharmaceuticals competitive analysis

Latest publications and patents of Teva Pharmaceuticals New

Explore the latest publications and patents granted to Teva Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 7, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Teva Pharmaceuticals

EP4097091
Sep 18, 2024Solid State Forms Of Mavacamten And Process For Preparation ThereofGranted And Under Opposition
EP3554581
Mar 13, 2024Medical Injection Device PackagingGranted And Under Opposition
EP3497104
Oct 6, 2021Solid State Forms Of Lumateperone Ditosylate SaltGranted And Under Opposition
EP3185938
Jun 3, 2020Compliance-Assisting Module For An Inhaler -
EP3344607
Nov 6, 2019Solid State Forms Of SelexipagRevoked
EP2897588
Jul 17, 2019An Inhalable MedicamentOpposition Rejected
EP3143998
May 22, 2019An Inhalable Medicament Comprising TiotropiumRevoked
EP3045182
Mar 7, 2018Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide And Methods Using SameRevoked
EP2326668
Jan 17, 2018Anti-Il-12/Il-23 AntibodiesNo Opposition Filed Within Time Limit
EP2796458
Jan 10, 2018Crystalline Raltegravir Sodium SaltsNo Opposition Filed Within Time Limit

Latest oppositions filed by Teva Pharmaceuticals

Explore patent oppositions filed by Teva Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP4321157
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 22, 2025
EP3242666
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 16, 2025
EP4062916
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICSJul 9, 2025
EP3226841
Anticancer CompositionsARAGON PHARMACEUTICALSJul 8, 2025
EP4065119
Methods Of Treating Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSJun 4, 2025
EP3801459
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 7, 2025
EP3840753
Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla GeneAMICUS THERAPEUTICSApr 23, 2025
EP3582814
Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSFeb 1, 2025
EP3335707
Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor AgonistGLAXO GROUPJan 17, 2025
EP3529360
Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionNOVARTISJan 17, 2025

Latest patents of Teva Pharmaceuticals opposed by its competitors

Explore Teva Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4097091
Sep 18, 2024Solid State Forms Of Mavacamten And Process For Preparation Thereof2
EP3554581
Mar 13, 2024Medical Injection Device Packaging2
EP3497104
Oct 6, 2021Solid State Forms Of Lumateperone Ditosylate Salt1
EP3344607
Nov 6, 2019Solid State Forms Of Selexipag2
EP2897588
Jul 17, 2019An Inhalable Medicament1
EP3143998
May 22, 2019An Inhalable Medicament Comprising Tiotropium1
EP3045182
Mar 7, 2018Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide And Methods Using Same2
EP2800567
Sep 27, 2017An Inhaler Comprising A Tiotropium-Containing-Composition1
EP3050556
Mar 22, 2017Process For Manufacturing A Pharmaceutical Preparation Containing Glatiramer Acetate2
EP2688877
Mar 8, 2017Solid State Forms Of Cabazitaxel And Processes For Preparation Thereof1

Latest PTAB cases involving Teva Pharmaceuticals New

Discover the latest PTAB cases involving Teva Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Teva Pharmaceuticals

IPR2022-01513Sep 9, 2022TEVA PHARMACEUTICALS USABAYER PHARMAFinal Written Decision - Appealed
IPR2022-00796Apr 11, 2022ELI LILLYTEVA PHARMACEUTICALSFinal Written Decision
IPR2022-00738Mar 23, 2022ELI LILLYTEVA PHARMACEUTICALSFinal Written Decision
IPR2022-00739Mar 23, 2022ELI LILLYTEVA PHARMACEUTICALSFinal Written Decision
IPR2020-01045Jun 10, 2020TEVA PHARMACEUTICALS USAMERCK SHARP & DOHMETerminated-Settled
PGR2019-00048May 7, 2019TEVA PHARMACEUTICALS USACORCEPT THERAPEUTICSFinal Written Decision
IPR2018-01712Oct 1, 2018ELI LILLYTEVA PHARMACEUTICALSFinal Written Decision
IPR2018-01711Oct 1, 2018ELI LILLYTEVA PHARMACEUTICALSFinal Written Decision
IPR2018-01710Sep 28, 2018ELI LILLYTEVA PHARMACEUTICALSFinal Written Decision
IPR2018-01427Aug 8, 2018ELI LILLYTEVA PHARMACEUTICALSFinal Written Decision

Top competitors of Teva Pharmaceuticals

Top competitors of Teva Pharmaceuticals based on patent oppositions.